Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.
Rollison DE, Komrokji R, Lee JH, Hampras S, Fulp W, Fisher K, Baz R, Nishihori T, Xu Q, Olesnyckyj M, Kenvin L, Knight R, Sullivan D, Alsina M, Dalton W, Shain KH.
Rollison DE, et al. Among authors: fisher k.
Leuk Lymphoma. 2017 Mar;58(3):560-568. doi: 10.1080/10428194.2016.1207763. Epub 2016 Jul 18.
Leuk Lymphoma. 2017.
PMID: 27424609
Free PMC article.